X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.gsk.com/en-gb/media/press-releases/european-commission-authorises-gsk-s-omjjara-momelotinib/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-gsks-anemia-treatment-2023-09-15/
https://www.onclive.com/view/combination-therapies-may-spur-evolution-of-the-myelofibrosis-treatment-paradigm
https://www.fiercebiotech.com/biotech/fda-delays-approval-decision-gsks-19b-blood-cancer-bet
https://www.fiercebiotech.com/biotech/gsk-explores-new-avenues-jak-drug-19b-sierra-buy-amid-pending-fda-decision
https://www.europeanpharmaceuticalreview.com/news/177098/ema-accepts-myelofibrosis-momelotinib-marketing-application/
https://www.pharmafile.com/news/740746/gsk-s-two-new-cancer-drugs-look-promising
http://www.pharmafile.com/news/730651/gsk-s-new-drug-application-momelotinib-accepted-fda
https://www.lse.co.uk/news/top-news-us-fda-accepts-gsks-new-drug-application-for-momelotinib-ezqjrdubgs8431c.html
https://www.fiercebiotech.com/biotech/gsk-inks-19b-sierra-takeover-3m-bet-gilead-castoff-turns-blockbuster-buyout
https://www.fiercebiotech.com/biotech/sierra-s-bet-gilead-castoff-pays-off-teeing-up-fda-filing-for-rival-to-incyte-novartis
https://www.biopharmadive.com/news/sierra-oncology-myelofibrosis-momelotinib-trial-results/617632/
https://www.prnewswire.com/news-releases/sierra-oncology-to-report-momelotinib-long-term-overall-survival-data-in-oral-presentation-at-ash-2020-301166773.html
https://www.prnewswire.com/news-releases/sierra-oncology-strengthens-management-team-to-implement-north-american-pre-commercialization-strategy-for-momelotinib-301106895.html
https://www.prnewswire.com/news-releases/sierra-oncology-reports-favorable-long-term-safety-and-dose-intensity-data-for-momelotinib-301074915.html
https://endpts.com/sierra-oncology-brings-on-former-aimmune-ceo-to-the-helm-flagship-woos-ex-novartis-exec-fabrice-chouraqui/
https://endpts.com/sierra-oncology-brings-on-former-aimmune-ceo-to-the-helm-flagship-woos-ex-novartis-exec-fabrice-chouraqui/
https://www.biopharmadive.com/news/meet-the-protein-responsible-for-nearly-100b-in-cancer-drug-deals/561097/
https://www.fiercebiotech.com/biotech/sierra-doubles-down-ex-gilead-drug-deprioritizes-other-assets?utm_source=internal&utm_medium=rss
https://www.cnbc.com/2018/08/23/gilead-paid-510m-for-drug-and-just-sold-it-for-3-million.html
Market Place
Share 
